Eli Lilly Shakes Up JPM25 with $2.5B Scorpion Buyout in Breast Cancer Battle
Eli Lilly kicked off the 2025 J.P. Morgan Healthcare Conference with a strategic acquisition of...
Read More
Category: Industry Trends
Johnson & Johnson Steals the Spotlight at JPM Conference with $14.6B Intra-Cellular Therapies Acquisition
On Monday, Johnson & Johnson (J&J) made headlines at the J.P. Morgan Healthcare Conference...
Read More
GSK snaps up IDRx for up to $1.15B
Britan-based pharmaceutical giant GSK has agreed to acquire 100% of the outstanding equity...
Read More
Transcarent paying $621M to acquire health benefits navigator Accolade
Transcarent has announced plans to acquire Accolade for $621 million, marking a significant step...
Read MorePfizer picks Triana Biomedicines to find Molecular Glues for Cancer
US pharmaceutical giant Pfizer announced a groundbreaking collaboration with Triana Biomedicines to develop Molecular Glue Degraders. The partnership aims to create multiple advanced therapies, including cancer. The...
Read More